Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

4 articles from the last 7 days matching "european medicines"

🔴 BreakingDrug approvalEMAYesterday

New medicine for two types of pulmonary fibrosis

The European Medicines Agency has approved a new medicine called Jascayd (nerandomilast) to treat adults with two types of lung scarring diseases: idiopathic pulmonary fibrosis and progressive fibrosing interstitial lung disease. This approval means the medicine is now available for patients in the European Union. This is the first time this particular medicine has been approved for these conditions in Europe.

WHY IT MATTERSPatients with idiopathic pulmonary fibrosis in the EU now have access to a newly approved treatment option that may help slow lung scarring and preserve breathing ability.
💬 Ask your doctoridiopathic pulmonary fibrosisprogressive fibrosing interstitial lung disease
Drug approvalEMAYesterday

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 May 2026

The European Medicines Agency approved eight new medicines in May 2026. The article mentions a few specific drugs, including Jascayd (nerandomilast) and Boey (trenibotulinumtoxinE), though details about what diseases they treat are incomplete in this announcement.

WHY IT MATTERSIf you have a rare disease, one of these eight newly approved medicines might be a treatment option available in Europe — check with your doctor to see if any match your condition.
💬 Ask your doctor
NewsEMA2 days ago

EMA closed on Whit Monday, 25 May

The European Medicines Agency (EMA) will be closed on Monday, May 25, 2026, for Whit Monday, a public holiday. The office will reopen at 8:30 AM on Tuesday, May 26. If you need emergency help with medicines during this time, a special hotline will still be available.

WHY IT MATTERSIf you need urgent help with a medicine approved in Europe during the holiday closure, you can still reach the EMA's emergency hotline instead of waiting until Tuesday.
Good to know

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases